Commitment COM-153
Post-approval commitment for CDSCO-2022-0053. Category: Risk Management. Priority: low.
Commitment ID
COM-153
Application
Authority
Central Drugs Standard Control Organisation
Category
Risk Management
Priority
low
Status
Overdue
Due Date
2025-02-07
Completed At
—
Owner
Dmitri Volkov
Created
2023-07-12
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.